[GRADE guidelines: 8. Rating the quality of evidence - indirectness].
暂无分享,去创建一个
Gerald Gartlehner | Holger J Schünemann | Angela Kaminski-Hartenthaler | Joerg J Meerpohl | H. Schünemann | G. Gartlehner | J. Meerpohl | A. Rasch | M. Perleth | G. Langer | Angela Kaminski-Hartenthaler | Matthias Perleth | Andrej Rasch | Gero Langer
[1] Keiji Fukuda,et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus , 2006, The Lancet Infectious Diseases.
[2] S D Walter,et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.
[3] D. Altman,et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery , 2003, BMJ : British Medical Journal.
[4] Douglas G Altman,et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews , 2009, BMJ : British Medical Journal.
[5] U. Siebert,et al. Progression-free survival as a surrogate endpoint in advanced breast cancer , 2008, International Journal of Technology Assessment in Health Care.
[6] J. Geddes,et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.
[7] Elie A Akl,et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. , 2008, Archives of internal medicine.
[8] D G Altman,et al. Indirect comparisons of competing interventions. , 2005, Health technology assessment.
[9] A. Sebba. Comparing non-vertebral fracture risk reduction with osteoporosis therapies: looking beneath the surface , 2009, Osteoporosis International.
[10] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[11] Juliette Martin,et al. Statin therapy-evidence beyond lipid lowering contributing to plaque stability. , 2006, Current medicinal chemistry.
[12] Deborah M Caldwell,et al. Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.
[13] Gordon H. Guyatt,et al. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.
[14] A. Tenenbaum,et al. Cardiovascular Diabetology BioMed Central Editorial Statins research unfinished saga: desirability versus feasibility , 2005 .
[15] P. Tugwell,et al. Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. , 2007, The Journal of rheumatology.
[16] Winfried März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005 .